Planned sale

Bridgebio Pharma (BBIO): Officer filed to sell ~$2.34M

KUMAR HALDEA FAMILY IRREVOCABLE TRUST, Officer at Bridgebio Pharma, filed to sell ~$2.34M of Bridgebio Pharma shares.

~$2.34M
planned to sell · 30K shares, around Nov 19, 2026
Planned for
Nov 19, 2026
Notice filed
Nov 19, 2026

What stands out in this filing

  • The planned sale is 0.02% of the company's shares outstanding, as stated on the notice.
  • How the shares were acquired, per the notice: Conversion Management Incentives Units.
  • Broker named on the notice: Morgan Stanley Smith Barney LLC Executive Financial Services.
  • A Form 144 announces a sale; the Form 4 that follows shows whether it took place, at what price.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 29, 2026CongressDisclosed partial sale of BBIO — reported range $1,001 - $15,000
  2. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 5.1%
  3. Oct 27, 2026CongressDisclosed purchase of BBIO — reported range $1,001 - $15,000
  4. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
  5. Oct 30, 2026InsiderOfficer sold ~$146K of BBIO shares in the open market
  6. Nov 2, 2026CongressDisclosed purchase of BBIO — reported range $1,001 - $15,000
  7. Nov 12, 20265% stakeFarallon Capital Management, L.L.C. reported a passive stake (13G) of 7.3%
  8. Nov 18, 2026Insider · 1 personInsiders: 4 sales (~$3.5M)
  9. Nov 19, 2026Insider · 1 personInsiders: 2 sales (~$785K)
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Bridgebio Pharma

For Bridgebio Pharma, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BBIO page.

How this filing works

Explore the data

Common questions

Which Bridgebio Pharma (BBIO) insider traded, and how much?

KUMAR HALDEA FAMILY IRREVOCABLE TRUST, Officer at Bridgebio Pharma, filed to sell ~$2.34M of Bridgebio Pharma shares. 30K shares, Form 144 notice of a planned sale.

When did it happen, and when was it made public?

Planned for: Nov 19, 2026. Notice filed: Nov 19, 2026.

What stands out in this filing?

The planned sale is 0.02% of the company's shares outstanding, as stated on the notice. How the shares were acquired, per the notice: Conversion Management Incentives Units. Broker named on the notice: Morgan Stanley Smith Barney LLC Executive Financial Services.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Bridgebio Pharma recently?

For Bridgebio Pharma, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the BBIO page.

Does this mean BBIO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Bridgebio Pharma

Everything OQRO holds on this company is on its BBIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data